SNDL Inc. says its described tender offer for its common shares has not yet commenced and may not proceed on the described terms or at all. If it commences, SNDL will file an offer to purchase, an accompanying issuer bid circular, a letter of transmittal and other tender-offer materials with the SEC and applicable Canadian securities regulators. The communication is informational and is not an offer to buy or a solicitation to sell SNDL common shares.
SNDL Inc. reported preliminary third-quarter 2026 free cash flow of approximately C$20 million, which it said would represent its highest quarterly result; the figure is unaudited and remains subject to quarter-end closing and review. Approximately C$10.6 million was associated with the initial unwinding of its captive insurance arrangement, net of related premium payments.
SNDL repurchased approximately 5.4 million shares in Q3 and approximately 21.8 million shares for C$43.4 million in the 12 months ended September 30, 2026. Its board directed management to pursue a possible substantial issuer bid for an aggregate purchase price not exceeding C$50 million and a price per share not greater than C$1.92 (US$1.35), a 17.4% premium to the October 14, 2026 closing price; launch is subject to exchange and cross-border regulatory approvals and would occur after Q3 earnings. The bid has not commenced.
Shareholders rejected the proposed share consolidation: 54.1% supported it, below the required two-thirds, so SNDL will not proceed under the authority sought. SNDL increased its indirect interest in Parallel from approximately 67% to approximately 92% after Parallel's rights offering. An agreement in principle with Ontario's Alcohol and Gaming Commission to resolve regulatory matters includes a $200,000 fine and is subject to definitive documentation.
SNDL Inc. (SNDL) announced it will release third-quarter 2026 financial results for the period ended September 30, 2026, before markets open on October 27, 2026. A conference call and webcast will follow at 10:00 a.m. EDT (8:00 a.m. MDT) that day.
SNDL Inc. announced that director Carlo Cannell resigned from its Board of Directors, effective immediately. The company thanked him for his contributions.
SNDL Inc. (SNDL) is convening a virtual-only annual and special shareholders’ meeting on October 15, 2026 at 10:00 a.m. Toronto time. Holders of common shares as of the August 26, 2026 record date, when 246,120,843 common shares were outstanding, may vote.
Shareholders will be asked to elect five directors, appoint CBIZ CPAs P.C. as auditor, and approve a share consolidation authorizing the board, within one year, to consolidate the stock between 1-for-2 and 1-for-10. The circular also details notice-and-access delivery of materials, proxy solicitation arrangements, and procedures for attending and voting at the virtual meeting.
SNDL Inc. reports the successful completion of a European Union Good Manufacturing Practice (EU-GMP) audit at its Atholville cultivation facility in New Brunswick. This milestone supports participation in regulated international medical cannabis markets and reflects an emphasis on quality, operational excellence, and regulatory compliance.
The Atholville facility spans approximately 380,000 square feet, including more than 110,000 square feet of cultivation canopy, and has production capacity of about 4,500 kilograms per quarter, with potential to support greater than 30 tonnes with targeted investment. The company anticipates receiving EU-GMP certification for Atholville within the next 90 days following the successful audit.
SNDL Inc. reported Q2 2026 net revenue of $235.8 million, down 3.7% year over year, with gross profit of $56.3 million and gross margin of 23.9%. The company recorded an operating loss of $7.8 million, a net loss of $7.8 million, an adjusted operating loss of $7.0 million and adjusted EBITDA of $12.5 million.
Liquor Retail revenue declined 5.1% as same‑store sales fell 6.2%, while Cannabis Operations net revenue dropped 10.1% and gross margin compressed to 1.8% due largely to Jeeter production ramp-up costs. Cannabis Retail remained comparatively resilient, with net revenue down 1.4% but gross margin improving to 26.4%. Free cash flow was a negative $6.7 million, though modestly better than a year earlier, and operating activities provided $3.7 million of cash.
Liquidity remains a core strength: cash and cash equivalents were $183.2 million, and unrestricted cash, marketable securities and investments totaled $598.5 million, with no debt. SNDL repurchased 11.7 million shares in Q2 and 29.0 million since Q4 2024. Completion of the Parallel restructuring gives majority economic exposure to U.S. medical cannabis operations expected to generate about US$150 million in annualized revenue, positioning SNDL to potentially exceed $1 billion in annual revenue and expand its vertically integrated North American footprint.
SNDL Inc. reported Q2 2026 net revenue of $235,766, down from $244,769 in Q2 2025, with gross profit of $56,349 and gross margin of 23.9%. The quarter shifted to an operating loss of $7,841 and a net loss of $7,822, versus prior-year net earnings of $2,885.
For the first six months of 2026, net revenue was $431,672 and net loss was $17,733. Cash and cash equivalents declined to $183,208, influenced by net share repurchases of 16.2 million shares for $33.1 million and negative free cash flow of $6,671 in Q2.
Through joint venture SunStream, SNDL’s interest in equity-accounted investees rose to $400,386. A restructuring of Surterra Holdings, Inc. (“Parallel”) was completed on July 27, 2026, giving SNDL indirect majority economic exposure to Parallel, which operates 56 retail locations plus cultivation and manufacturing facilities in the United States.
SNDL Inc. completed the Parallel Transaction, acquiring operating assets of Surterra Holdings and affiliates in Florida, Texas and Massachusetts through a strict foreclosure and related restructuring. Via its Sunstream joint venture, SNDL now has indirect majority economic exposure to 66.7% of TransactionCo’s equity and 69.4% of its debt.
The acquired platform includes 56 retail locations and three cultivation and manufacturing facilities with annualized revenue of about US$150 million, contributing to what CEO Zach George described as a 249-store global cannabis retail network. The restructuring extinguished approximately US$842 million of Parallel debt and leaves SNDL positioned to seek direct, consolidated exposure to U.S. medical cannabis operations, subject to legal, regulatory, accounting and Nasdaq requirements. A US$29.75 million loan position was also acquired at a 25% discount and continues to be accounted for using the equity method, with broader financial reporting changes expected once SNDL secures direct operational control.
SNDL Inc. announced it will release its second quarter 2026 financial results for the period ended June 30, 2026 before markets open on July 28, 2026. The company will then hold a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) that same day, accessible via an online webcast link.
SNDL is described as one of the largest vertically integrated cannabis companies and the largest private-sector liquor and cannabis retailer in Canada, operating banners including Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf and Cost Cannabis. Its consumer-facing cannabis brands include offerings such as Top Leaf, Palmetto, Value Buds, Grasslands, Vacay, Pearls by Grön, No Future and Bhang Chocolate, and it also deploys strategic capital across the North American cannabis industry.